Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of blood donation on bone marrow harvest efficiency.
Mitrus I, Wilkiewicz M, Fidyk W, Ciomber A, Smagur A, Glowala-Kosinska M, Chwieduk A, Borzdzilowska P, Sobczyk-Kruszelnicka M, Mendrek W, Najda J, Czerw T, Giebel S. Mitrus I, et al. Among authors: najda j. Bone Marrow Transplant. 2022 Mar;57(3):507-509. doi: 10.1038/s41409-022-01573-1. Epub 2022 Jan 18. Bone Marrow Transplant. 2022. PMID: 35042980 Free PMC article. No abstract available.
Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
Mitrus I, Smagur A, Fidyk W, Czech M, Prokop M, Chwieduk A, Glowala-Kosinska M, Czerw T, Sobczyk-Kruszelnicka M, Mendrek W, Michalak K, Sadus-Wojciechowska M, Najda J, Holowiecki J, Giebel S. Mitrus I, et al. Among authors: najda j. Bone Marrow Transplant. 2018 Mar;53(3):274-280. doi: 10.1038/s41409-017-0056-6. Epub 2017 Dec 21. Bone Marrow Transplant. 2018. PMID: 29269805 Clinical Trial.
Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma.
Giebel S, Sobczyk-Kruszelnicka M, Blamek S, Saduś-Wojciechowska M, Najda J, Czerw T, Mendrek W, Woźniak G, Jochymek B, Radwan M, Leszczyński W, Dolla Ł, D'Amico A, Ślosarek K, Hołowiecki J, Miszczyk L. Giebel S, et al. Among authors: najda j. Bone Marrow Transplant. 2021 Jun;56(6):1297-1304. doi: 10.1038/s41409-020-01181-x. Epub 2020 Dec 18. Bone Marrow Transplant. 2021. PMID: 33339899 Clinical Trial.
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
Giebel S, Kruzel T, Czerw T, Sadus-Wojciechowska M, Najda J, Chmielowska E, Grosicki S, Jurczyszyn A, Pasiarski M, Nowara E, Glowala-Kosinka M, Chwieduk A, Mitrus I, Smagur A, Holowiecki J. Giebel S, et al. Among authors: najda j. Bone Marrow Transplant. 2013 Jul;48(7):915-21. doi: 10.1038/bmt.2012.269. Epub 2013 Jan 7. Bone Marrow Transplant. 2013. PMID: 23292239 Clinical Trial.
Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy.
Głowala-Kosińska M, Chwieduk A, Smagur A, Fidyk W, Najda J, Mitrus I, Giebel S. Głowala-Kosińska M, et al. Among authors: najda j. Biol Blood Marrow Transplant. 2016 May;22(5):834-42. doi: 10.1016/j.bbmt.2016.01.014. Epub 2016 Jan 19. Biol Blood Marrow Transplant. 2016. PMID: 26797400 Free article.
Immunological properties of bone marrow microenvironment 1 year after allogeneic hematopoietic stem cell transplantation.
Ciomber A, Mitrus I, Fidyk W, Smagur A, Chwieduk A, Glowala-Kosinska M, Czerw T, Sobczyk-Kruszelnicka M, Mendrek W, Sadus-Wojciechowska M, Najda J, Holowiecki J, Giebel S. Ciomber A, et al. Among authors: najda j. Exp Hematol. 2016 Dec;44(12):1172-1180.e1. doi: 10.1016/j.exphem.2016.08.001. Epub 2016 Aug 12. Exp Hematol. 2016. PMID: 27524270 Free article.
Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial.
Czerw T, Sadus-Wojciechowska M, Michalak K, Najda J, Mendrek W, Sobczyk-Kruszelnicka M, Glowala-Kosinska M, Chwieduk A, Mitrus I, Smagur A, Holowiecki J, Giebel S. Czerw T, et al. Among authors: najda j. Biol Blood Marrow Transplant. 2019 Feb;25(2):248-255. doi: 10.1016/j.bbmt.2018.09.023. Epub 2018 Sep 26. Biol Blood Marrow Transplant. 2019. PMID: 30266677 Free article. Clinical Trial.
Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A, Mitrus I, Giebel S, Sadus-Wojciechowska M, Najda J, Kruzel T, Czerw T, Gliwinska J, Prokop M, Glowala-Kosinska M, Chwieduk A, Holowiecki J. Smagur A, et al. Among authors: najda j. Vox Sang. 2013 Apr;104(3):240-7. doi: 10.1111/j.1423-0410.2012.01657.x. Epub 2012 Oct 9. Vox Sang. 2013. PMID: 23046417
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Giebel S, Sadus-Wojciechowska M, Halaburda K, Drozd-Sokolowska J, Wierzbowska A, Najda J, Mendrek W, Sobczyk-Kruszelnicka M, Nowicki M, Holowiecki J, Czerw T. Giebel S, et al. Among authors: najda j. Ann Hematol. 2016 Jan;95(2):263-9. doi: 10.1007/s00277-015-2557-y. Epub 2015 Nov 27. Ann Hematol. 2016. PMID: 26611854
Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation.
Frankiewicz A, Saduś-Wojciechowska M, Najda J, Czerw T, Mendrek W, Sobczyk-Kruszelnicka M, Soska K, Ociepa M, Hołowiecki J, Giebel S. Frankiewicz A, et al. Among authors: najda j. Contemp Oncol (Pozn). 2018;22(2):113-117. doi: 10.5114/wo.2018.77046. Epub 2018 Jun 30. Contemp Oncol (Pozn). 2018. PMID: 30150889 Free PMC article.
36 results